Tremfya offers self injection or intravenous infusion from the start.
Tremfya: Self injection or intravenous infusion from the start · May 14–19, 2026
ChurnedTremfya advertising observed across this podcast campaign.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Shows
Where the campaign appearedRepresentative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremfya offers self injection or intravenous infusion from the start. Tremfya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks.
More campaigns from Tremfya
Other published campaigns from this sponsor
This campaign promotes Tremfya as a prescription medicine for adults with moderately to severely active Crohn's disease or ulcerative colitis, emphasizing the choice between self-injection or intravenous infusion from the start.
This campaign promotes Tremfya as a prescription medicine for adults with moderate to severe plaque psoriasis and active psoriatic arthritis, addressing symptoms like joint pain and swelling by offering a path to relief.
Tremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and ulcerative colitis, providing options for self-injection or intravenous infusion.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.